Biopharmaceutical News and Research

RSS

FDA approves brexanolone, first drug developed to treat postpartum depression

Approximately 1 in 9 women in the United States experiences symptoms of postpartum depression, according to the Centers for Disease Control and Prevention.

21 Mar 2019

First postpartum depression drug gets FDA nod

Sage therapeutics’ Zulresso became the first drug approved for postpartum depression by the United States Food and Drugs Administration (FDA). This cause the shares of Sage to rise by over 5 percent on Tuesday this week.

20 Mar 2019

Pall Corporation expands collaboration agreement with ARTeSYN Biosolutions

Pall Corporation, a global leader in filtration, separation and purification, announced the next step in the collaboration agreement with ARTeSYN Biosolutions, a leading innovator in single-use components and fluid management technologies.

From Pall Corporation 14 Mar 2019

Parkinson's disease: Servier and Oncodesign announce research and drug development partnership

Servier and Oncodesign have announced a strategic partnership for the research and development of potential drug candidates for Parkinson's disease.

12 Mar 2019

ACROBiosystems opens new Innovation laboratory in Delaware

January 18, 2018, ACROBiosystems officially opened its New Innovation laboratory in the Delaware Innovation Space in Wilmington, Delaware, USA, and held a grand opening ceremony.

From ACROBiosystems 7 Mar 2019

SSB and Novasep collaborate to develop new membrane chromatography systems

Sartorius Stedim Biotech, a leading supplier for the biopharmaceutical industry, and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing.

From Sartorius 6 Mar 2019

FutureNeuro collaborates with UCB to inform improvements in epilepsy treatment

FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI, has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy.

5 Mar 2019

Translucent wonder material used on stadium roofs helps measure protein particles

Understanding how proteins clump together is essential in modern pharmaceuticals. When these tiny particles aggregate, they can alter the effectiveness of both vaccines and drugs, especially many of the new, popular formulations derived from monoclonal antibodies.

1 Mar 2019

Sartorius successfully closes fiscal year 2018 and plans to continuously expand

Sartorius, a leading international partner of biopharmaceutical research and the industry, confirmed its preliminary figures with the publication of its 2018 Annual Report.

From Sartorius 21 Feb 2019

Machine learning algorithm could accelerate the search for new drugs

Researchers have designed a machine learning algorithm for drug discovery which has been shown to be twice as efficient as the industry standard, which could accelerate the process of developing new treatments for disease.

12 Feb 2019

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

As marijuana legalization sweeps North America, use of the substance has been on the rise, and the public's attitude is shifting. An increasing number of people believe that "weed" is the safest recreational drug, one that carries health benefits that outweigh its risks.

11 Feb 2019

Oxford Genetics signs licensing agreement with Aldevron to market lentiviral packaging plasmids

Oxford Genetics, a leading innovator of biopharmaceutical technologies, has signed a licensing agreement with world-class service organization, Aldevron to bring to market a standardized range of its plasmids for lentiviral manufacture.

1 Feb 2019

Newron announces successful completion of patient enrollment in STARS study

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced the successful completion of patient enrollment in its STARS clinical study.

1 Feb 2019

Sartorius becomes member of the NIIMBL organization

Sartorius, a leading international partner of biopharmaceutical research and the industry, is pleased to announce that it has joined NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals headquartered in Newark, Delaware, USA.

From Sartorius 1 Feb 2019

New drug for sleeping sickness approved in the Democratic Republic of Congo

Marketing authorization of fexinidazole for the treatment of Trypanosoma brucei gambiense human African trypanosomiasis (HAT), more commonly known as sleeping sickness, has been granted in the Democratic Republic of Congo (DRC).

31 Jan 2019

Synchron and Festo introduce new ultra-high throughput DNA extraction device at SLAS 2019

During SLAS 2019, Synchron and Festo will describe the recent technology breakthrough leading to ultra-high throughput DNA extraction – up to 38,400 extractions per 24 hours.

From Society for Laboratory Automation and Screening (SLAS) 30 Jan 2019

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation, a leader in the industry for the design and manufacture of automated laboratory equipment, will collaborate to offer automated micro-plate handling capabilities for single cell analysis.

30 Jan 2019

Biopharmaceutical News and Research

FDA approves brexanolone, first drug developed to treat postpartum depression

First postpartum depression drug gets FDA nod

Pall Corporation expands collaboration agreement with ARTeSYN Biosolutions

Parkinson's disease: Servier and Oncodesign announce research and drug development partnership

ACROBiosystems opens new Innovation laboratory in Delaware

SSB and Novasep collaborate to develop new membrane chromatography systems

FutureNeuro collaborates with UCB to inform improvements in epilepsy treatment

Translucent wonder material used on stadium roofs helps measure protein particles

Sartorius successfully closes fiscal year 2018 and plans to continuously expand

Machine learning algorithm could accelerate the search for new drugs

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

Oxford Genetics signs licensing agreement with Aldevron to market lentiviral packaging plasmids

Newron announces successful completion of patient enrollment in STARS study

Sartorius becomes member of the NIIMBL organization

New drug for sleeping sickness approved in the Democratic Republic of Congo

Synchron and Festo introduce new ultra-high throughput DNA extraction device at SLAS 2019

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

Cognetivity signs agreement to become ninth industry partner of Dementias Platform UK

Sartorius Stedim Biotech launches NBE product characterization service

Lab-Scale Clarification of Mammalian Cell Cultures Expressing Recombinant Antibodies

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News